Mobilization of Hematopoietic Stem Cells into Peripheral Blood for Autologous Transplantation Seems Less Efficacious in Poor Mobilizers with the Use of a Biosimilar of Filgrastim and Plerixafor: A Retrospective Comparative Analysis

Mobilization of Hematopoietic Stem Cells into Peripheral Blood for Autologous Transplantation Seems Less Efficacious in Poor Mobilizers with the Use of a Biosimilar of Filgrastim and Plerixafor: A Retrospective Comparative Analysis

Abstract Introduction Biosimilars of granulocyte colony-stimulating factors (G-CSF) have shown similar efficacy to originator filgrastim (Neupogen® [NEU]; Amgen Inc.) as prophylaxis in neutropenia and in the mobilization of stem cells in patients receiving combination chemotherapy with G-CSF. Method...

Full description

Bibliographic Details
Main Authors: Rocío Parody, Isabel Sánchez-Ortega, Christelle Ferrá, Ramon Guardia, Carme Talarn, Maite Encuentra, Eduard Fort, David López, Mireia Morgades, Eva Alonso, Sandra Ortega, Josep Sarrá, David Gallardo, Josep M. Ribera, Anna Sureda
Format: Article
Language:English
Published: Adis, Springer Healthcare 2020-05-01
Series:Oncology and Therapy
Subjects:
Biosimilars
Plerixafor
Stem cell mobilization
Online Access:https://doi.org/10.1007/s40487-020-00115-3

Internet

https://doi.org/10.1007/s40487-020-00115-3

Similar Items